AEON Biopharma, Inc. (AMEX:AEON) Financings

AEON Biopharma, Inc.

Financings

RaiseDate
Public offering of underwritten public offering with milestone warrants
Closed: US$15.3M raised · US$0.3221 a share · one two-year milestone warrant (exercise price $0.3221) and one five-year milestone… · Lake Street Capital Markets, LLC +1
Dealers: Lake Street Capital Markets, LLC (lead), Laidlaw & Company (UK) Ltd.
Use of proceeds: Cash runway into the first quarter of 2027, supporting advancement of the ABP-450 development program
Aug 12, 2026
Private placement of pIPE financing
Tranche closed: US$1.79M raised
Use of proceeds: Uninterrupted execution of the analytical program and acceleration of ABP-450 biosimilar development
Jan 21, 2026

Read by 6ix AI from the company's releases